The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic.
Montaner
Julio S G
JS
British Columbia Centre for Excellence in HIV/AIDS, Providence Health Care, University of British Columbia, Vancouver, Canada. jmontaner@cfenet.ubc.ca
Hogg
Robert
R
Wood
Evan
E
Kerr
Thomas
T
Tyndall
Mark
M
Levy
Adrian R
AR
Harrigan
P Richard
PR
D023241:Antiretroviral Therapy, Highly Active / Q000191:economics*; D003362:Cost-Benefit Analysis; D005260:Female; D014943:Global Health; D015658:HIV Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D006801:Humans; D015994:Incidence; D008297:Male